Sanofi Consumer Healthcare Stock Screener | Share Price & Fundamental Analysis
SANOFICONR
Pharmaceuticals
Share Price NSE
₹4530.50
▼
-110.60 (-2.38%)
Share Price BSE
₹4532.45
▼
-112.15 (-2.41%)
Track Sanofi Consumer Healthcare share price live with TickJournal's free stock screener.
Analyze Sanofi Consumer Healthcare share price history trends and compare 52-week high low
levels.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Sanofi Consumer Healthcare Market Cap
₹10,543.65 Cr.
SANOFICONR P/E Ratio (TTM)
43.56
Sanofi Consumer Healthcare P/B Ratio
27.23
EPS (TTM)
₹78.59
Dividend Yield
-
Debt to Equity
0.04
SANOFICONR 52 Week High
₹5696.00
Sanofi Consumer Healthcare 52 Week Low
₹3999.50
Operating Margin
35.00%
Profit Margin
26.58%
SANOFICONR Revenue (TTM)
₹903.00
EBITDA
₹334.00
Net Income
₹240.00
Total Assets
₹431.00
Total Equity
₹273.00
Sanofi Consumer Healthcare Share Price History - Stock Screener Chart
Screen SANOFICONR historical share price movements with interactive charts. Analyze price trends and patterns.
Sanofi Consumer Healthcare Company Profile - Fundamental Screener
Screen Sanofi Consumer Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SANOFICONR shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0UOS01011
Sanofi Consumer Healthcare Balance Sheet Screener
Screen SANOFICONR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2024 | 2023 |
|---|---|---|
| Assets | ||
| Total Assets | 431 | 345 |
| Current Assets | 392 | 335 |
| Fixed Assets | 29 | 5 |
| Liabilities | ||
| Total Liabilities | 0 | 0 |
| Current Liabilities | 28 | 8 |
| Non-Current Liabilities | 0 | 0 |
| Shareholders' Equity | ||
| Total Equity | 273 | 208 |
| Share Capital | 23 | 2 |
| Reserves & Surplus | 250 | 183 |
Sanofi Consumer Healthcare Income Statement Screener - Profit & Revenue Analysis
Screen Sanofi Consumer Healthcare income statement and profit fundamentals.
Analyze SANOFICONR quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Sanofi Consumer Healthcare share price evaluation.
| Item | None-None | 2024-March | 2023-March |
|---|---|---|---|
| Revenue | 903 | 738 | 560 |
| Expenses | 569 | 454 | 337 |
| EBITDA | 334 | 284 | 223 |
| Operating Profit % | 35.00% | 37.00% | 39.00% |
| Depreciation | 12 | 5 | 2 |
| Interest | 2 | 4 | 0 |
| Profit Before Tax | 320 | 247 | 219 |
| Tax | 82 | 66 | 54 |
| Net Profit | 240 | 181 | 165 |
| EPS | 104.20 | 78.59 | 71.60 |
Sanofi Consumer Healthcare Cash Flow Screener - Liquidity Fundamentals
Screen SANOFICONR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2024-March | 2023-March |
|---|---|---|
| Operating Activities | 439 | 0 |
| Investing Activities | 2 | 0 |
| Financing Activities | -116 | 2 |
| Net Cash Flow | 325 | 2 |
Sanofi Consumer Healthcare Shareholding Pattern Screener
See Sanofi Consumer Healthcare shareholding pattern with promoter, FII, and DII holdings.
Check Sanofi Consumer Healthcare promoter holding and ownership changes for SANOFICONR on TickJournal.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Oct | 2024-Sept | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 71.27% | 71.27% | 71.27% | 60.40% | 60.40% | 60.40% | 60.40% | 60.40% |
| FII Holding | 2.83% | 2.94% | 3.24% | 4.53% | 4.42% | 4.87% | 5.22% | 0.00% |
| DII Holding | 17.33% | 17.21% | 16.89% | 25.48% | 25.35% | 24.51% | 24.03% | 20.87% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 6.25% | 6.26% | 6.30% | 6.58% | 7.01% | 7.41% | 7.53% | 7.71% |
| Other Holding | 2.31% | 2.32% | 2.30% | 3.01% | 2.83% | 2.82% | 2.83% | 11.03% |
| Shareholder Count | 48,075 | 48,808 | 49,632 | 51,859 | 55,734 | 57,598 | 61,091 | 61,091 |
Sanofi Consumer Healthcare Share Dividend Screener - Share Yield Analysis
Check Sanofi Consumer Healthcare dividend history with payout and yield data.
View Sanofi Consumer Healthcare dividend details including ex-dates and amounts for SANOFICONR stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹55.00 | 1.14% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Sanofi Consumer Healthcare Stock Index Membership
See which indices include Sanofi Consumer Healthcare stock.
Check SANOFICONR index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE INDEX BSE HC
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT
Sanofi Consumer Healthcare Market Events Screener - Corporate Actions
Get Sanofi Consumer Healthcare corporate actions including splits, bonuses, and buybacks.
Check Sanofi Consumer Healthcare stock events that may affect SANOFICONR share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-02-25 | 2026-02-25 | Quarterly Result Announcement | NA | -4.76% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -5.60% |
| 2025-08-04 | 2025-08-04 | Quarterly Result Announcement | NA | -2.10% |
| 2025-05-05 | 2025-05-05 | Annual General Meeting | NA | 3.96% |
| 2025-05-02 | 2025-05-02 | Quarterly Result Announcement | NA | 0.05% |
| 2025-04-17 | 2025-04-17 | Dividend | ₹ 55.00 /share | 5.07% |
| 2025-02-20 | 2025-02-20 | Quarterly Result Announcement | NA | 0.62% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 0.97% |
Sanofi Consumer Healthcare Competitors Screener - Peer Comparison
Screen SANOFICONR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 406,351 | 37.86 | 54,729 | 9.71% | 10,980 | 37.98 |
| Divis Laboratories | 155,472 | 63.26 | 9,712 | 18.67% | 2,191 | 33.24 |
| Torrent Pharmaceuticals | 134,945 | 61.20 | 11,539 | 6.99% | 1,911 | 32.75 |
| Lupin | 103,954 | 22.26 | 22,910 | 13.74% | 3,306 | 47.35 |
| Dr Reddys Laboratories | 101,601 | 18.27 | 33,741 | 16.73% | 5,725 | 39.36 |
| Cipla | 96,320 | 21.31 | 28,410 | 7.12% | 5,291 | 26.86 |
| Zydus Life Science | 86,964 | 17.29 | 23,511 | 18.55% | 4,615 | 41.42 |
| Mankind Pharma | 82,499 | 45.81 | 12,744 | 20.90% | 2,007 | 41.40 |
| Aurobindo Pharma | 77,462 | 22.37 | 32,346 | 9.43% | 3,484 | 64.38 |
| Alkem Laboratories | 62,867 | 25.87 | 13,458 | 3.70% | 2,216 | 42.54 |
Sanofi Consumer Healthcare Company Announcements - News Screener
Screen SANOFICONR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-01 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-03-31 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-03-30 | Closure of Trading Window | - |
| 2026-03-29 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-03-29 | Publication of Postal Ballot Notice | - |
| 2026-03-23 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
| 2026-03-19 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-03-01 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-02-27 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-25 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-02-25 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-02-25 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-02-25 | Re-Appointment Of M/S. Kishore Bhatia & Associates As The Cost Auditor Of The Company For The Financial Year Ending 31St December 2026 | - |
| 2026-02-25 | Corporate Action-Board approves Dividend | - |
| 2026-02-25 | Outcome Of Board Meeting For Approval Of Audited Financial Results Of The Company For The Quarter And Financial Year Ended 31St December 2025 | - |
| 2026-02-25 | Board Meeting Outcome for Outcome Of Board Meeting For Approval Of Audited Financial Statements Of The Company For The Quarter And Financial Year Ended 31St December 2025 | - |
| 2026-02-20 | Update on board meeting | - |
| 2026-02-17 | Board Meeting Intimation for For Considering And Approving Audited Financial Statements For The Quarter And Financial Year Ended 31St December 2025 | - |
| 2026-01-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-26 | Closure of Trading Window | - |